Stephanie Mehlis to Severity of Illness Index
This is a "connection" page, showing publications Stephanie Mehlis has written about Severity of Illness Index.
Connection Strength
0.067
-
From laboratory to clinic: rationale for biologic therapy. Dermatol Clin. 2004 Oct; 22(4):371-7, vii-viii.
Score: 0.042
-
Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate-to-severe plaque psoriasis: 52-week results from the CLEAR study. J Eur Acad Dermatol Venereol. 2017 Oct; 31(10):1693-1699.
Score: 0.025